Delivery Order SPE2DB22D2006-SPE2DB24FV9XV
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,177.10 for the supply of the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,483.36 firm fixed-price delivery order is for the supply of 4564682113 TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The award has a completion date of May 23, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $1,741.68 firm fixed-price delivery order for the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 3, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order worth $5,551.42 for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of April 22, 2024 and is structured as a Firm Fixed Price agreement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order from the Defense Logistics Agency (DLA) valued at $1,451.40 for the pharmaceutical product Trulicity 0.75 mg/0.5 mL pen. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $4,685.57 with a completion date of March 20, 2025. The contract is a Firm Fixed Price agreement awarded by the Defense Logistics Agency (DLA) for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The award value is $1,278.98 and has an ultimate completion date of April 24, 2024. The contract is a firm fixed-price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. Amerisourcebergen, a major pharmaceutical distribution company, has a significant Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order contract valued at $4,354.20. The contract is for the supply of the pharmaceutical product TRULICITY 0.75 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of July 2, 2024. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has a significant...
- This federal contract award is a delivery order valued at $8,223.12, issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of April 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, worth $3,483.36, for the supply of 4565110247 TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV9XVDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $3,483.36 for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The award was made by the Defense Logistics Agency (DLA), a defense agency of the U.S. government, and the ultimate completion date is April 30, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. These contracts highlight Amerisourcebergen's expertise and competitive position in the federal pharmaceutical supply market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 4/29/24 |